| ISIN | LU1045227185 |
|---|---|
| Valor Number | 23884624 |
| Bloomberg Global ID | |
| Fund Name | Cadmos-Swiss Equitues B |
| Fund Provider |
de Pury Pictet Turrettini & Cie S.A.
Genève 11, Switzerland Phone: +41 22 317 00 30 E-Mail: contact@ppt.ch Web: www.ppt.ch |
| Fund Provider | de Pury Pictet Turrettini & Cie S.A. |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) |
Pictet Asset Management SA. Genève 73 Phone: +41 58 323 30 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 238.81 CHF | 09.01.2026 |
|---|---|---|
| Previous Price * | 237.79 CHF | 08.01.2026 |
| 52 Week High * | 238.81 CHF | 09.01.2026 |
| 52 Week Low * | 191.41 CHF | 09.04.2025 |
| NAV * | 238.81 CHF | 09.01.2026 |
| Issue Price * | 238.81 CHF | 09.01.2026 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 57,410,614 | |
| Unit/Share Assets *** | 33,570,319 | |
| Trading Information SIX | ||
| YTD Performance | +1.99% |
31.12.2025 - 09.01.2026
31.12.2025 09.01.2026 |
|---|---|---|
| 1 month | +3.35% |
09.12.2025 - 09.01.2026
09.12.2025 09.01.2026 |
| 3 months | +3.17% |
09.10.2025 - 09.01.2026
09.10.2025 09.01.2026 |
| 6 months | +5.39% |
09.07.2025 - 09.01.2026
09.07.2025 09.01.2026 |
| 1 year | +8.02% |
09.01.2025 - 09.01.2026
09.01.2025 09.01.2026 |
| 2 years | +16.74% |
09.01.2024 - 09.01.2026
09.01.2024 09.01.2026 |
| 3 years | +22.57% |
09.01.2023 - 09.01.2026
09.01.2023 09.01.2026 |
| 5 years | +22.50% |
11.01.2021 - 09.01.2026
11.01.2021 09.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 7.49% | |
|---|---|---|
| Swiss Life Holding AG | 6.12% | |
| ABB Ltd | 5.47% | |
| Swissquote Group Holding SA | 4.77% | |
| Zurich Insurance Group AG | 4.73% | |
| Compagnie Financiere Richemont SA Class A | 4.52% | |
| Novartis AG Registered Shares | 4.36% | |
| Lonza Group Ltd | 3.96% | |
| Givaudan SA | 3.86% | |
| Belimo Holding AG | 3.77% | |
| Last data update | 30.09.2025 | |
| TER *** | 1.13% |
|---|---|
| TER date *** | 30.11.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.75% |
| Ongoing Charges *** | 1.13% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |